Is there variation between hospitals within each region in postoperative mortality for lung cancer surgery in France? A nationwide study from 2013 to 2020.

Front Med (Lausanne)

Service de Biostatistiques et d'Information Médicale (DIM), CHU Dijon Bourgogne, INSERM, Université de Bourgogne, CIC 1432, Module Épidémiologie Clinique, Dijon, France.

Published: March 2023

AI Article Synopsis

  • The study assesses the quality of thoracic surgery for lung cancer in France by analyzing 30-day post-operative mortality rates across different hospitals and regions from 2013 to 2020.
  • Data from over 87,000 patients revealed a 2.91% mortality rate, with significant variability in standardized mortality ratios (SMRs) among 199 hospitals, particularly in high-volume regions.
  • The findings indicate that while regional differences in mortality exist, the volume of surgeries performed at hospitals greatly influences the likelihood of post-operative death, highlighting the importance of hospital experience in surgical outcomes.

Article Abstract

Introduction: The practice of thoracic surgery for lung cancer is subject to authorization in France. We evaluated the performance of hospitals using 30-day post-operative mortality as a quality indicator, estimating its distribution within each region and measuring its variability between regions.

Material And Methods: All data for patients who underwent pulmonary resection for lung cancer in France (2013-2020) were collected from the national hospital administrative database. Thirty-day mortality was defined as any patient who died in hospital (including transferred patients) within the first 30 days after the operation and those who died later during the initial hospitalization. The Standardized Mortality ratio (SMR) was the smoothed, adjusted, hospital-specific mortality rate divided by the expected mortality. To describe the variation in hospital mortality between hospitals in each region, we used different commonly used indicators of variation such as coefficients of variation (CV), interquartile interval or range (IQR), extreme ratio, and systematic component of variance (SCV).

Results: In 2013-2020, 87,232 patients underwent lung resection for cancer in France. The number of deaths was 2,537, a rate of 2.91%. The median SMR of 199 hospitals was 0.99 with an IQR of 0.86 to 1.18 and a CV of 0.25. Among the regions that had the most hospitals performing lung resections for cancer, the extreme ratio was >2, which means that the maximum value is twice as high as the minimum value. The SCV between hospitals was >10 for two of these regions, which is considered indicative of very high variation. For the other regions (with few hospitals performing lung resections for cancer), the variation between hospitals was lower. Globally, the variability between regions concerning the SMR was moderate, 6% of the variance was due to differences across regions. On the contrary, the hospital volume was significantly related to the SMR ( = 0.003) with a negative linear trend, whatever the region.

Conclusion: This work shows significant differences in the practices of the various hospitals within regions. However, overall, the variability in the 30-day mortality rate between regions was moderate. Our findings raises questions regarding the regionalization of major surgical procedures in France.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043397PMC
http://dx.doi.org/10.3389/fmed.2023.1110977DOI Listing

Publication Analysis

Top Keywords

lung cancer
12
variation hospitals
8
hospitals region
8
mortality
8
hospitals
8
patients underwent
8
cancer france
8
mortality rate
8
extreme ratio
8
regions hospitals
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!